HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
QURE
uniQure N.V.
Healthcare Biotechnology · Netherlands · Reports in usd
Market Cap: $3.05B
Market Cap
$3.05B
Enterprise Val
$2.79B
P/E Ratio
-12.10
P/B Ratio
9.41
Trailing PEG (1Y)
-0.16
As Of
Aug 20, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$324.1M
Gross Margin94.01%
Profit Margin94.01%
Return on Equity-111.96%
Return on Assets-29.01%
Current Ratio10.01
Debt/Equity1.70
LT Debt/Equity1.69
Revenue Per Share0.09

Income Statement

Jun 30, 2026
Revenue$5.8M
Cost of Revenue$350.0K
Gross Profit$5.5M
R&D$34.0M
SG&A$17.4M
Operating Expenses$57.7M
Operating Income-$52.2M
Interest Expense$14.4M
Tax Expense$1.8M
Net Income-$81.1M
EPS (Basic)$-1.22
EPS (Diluted)$-1.22
EBIT-$64.9M
EBITDA-$59.9M
Consolidated Income-$81.1M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$413.0M
Accounts Receivable$5.8M
Inventory$0.00
Current Assets$834.3M
LT Investments$30.3M
Property, Plant & Equipment$23.0M
Intangibles$86.7M
Non-Current Assets$150.8M
Total Assets$985.1M
Accounts Payable$5.0M
Current Debt$3.0M
Current Liabilities$83.3M
LT Debt$549.2M
Non-Current Liabilities$577.7M
Total Liabilities$661.1M
Total Debt$552.2M
Retained Earnings-$1.46B
Shareholder Equity$324.1M
Shares Outstanding63,067,485

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$28.6M
Investing Cash Flow$53.3M
Financing Cash Flow$249.1M
CapEx-$472.0K
Free Cash Flow-$29.0M
Depreciation & Amort.$4.9M
Stock-Based Comp$5.0M
Acquisitions / Disposals$0.00
Investment Activity$53.7M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$249.1M
Dividends Paid$0.00
Net Change in Cash$273.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h